| FAST |
Report |
Net sales / daily sales growth |
BEAT |
pred ~$2.365B (~13.5% daily sales growth) vs. cons ~$2.34B (~12.6% growth) |
MEDIUM |
| FAST |
Report |
EPS |
MISS |
pred ~$0.32 vs. cons ~$0.33 |
MEDIUM |
| FAST |
Report |
Gross margin |
MISS |
pred ~44.1% vs. cons ~44.6% |
MEDIUM |
| FAST |
Guide |
Gross margin trajectory / price-cost catch-up |
UNCHANGED |
guide ~44.8-45.0% recovery vs. cons ~44.8% (Q3 2026) |
LOW |
| FAST |
Guide |
FY2026 net capex guidance |
UNCHANGED |
guide ~$310-330M (reaffirmed) vs. cons ~$315M embedded (FY2026) |
MEDIUM |
| FAST |
Guide |
Cumulative price realization framework |
UNCHANGED |
guide ~5-8% cumulative pricing (management framework) vs. cons ~6% implied (FY2026) |
LOW |
| FAST |
Return |
Day-1 residual (stock − beta × S&P 500) |
-3.5% |
— |
MEDIUM |
| FAST |
Return |
5-day cumulative residual |
-4.5% (FOLLOW-THROUGH) |
A second straight quarter of gross-margin shortfall (after Q1's ~40bps miss) alongside a fading SG&A/incentive-comp tailwind implies FY26 EPS estimates get trimmed for H2, not just Q2 — analysts will push out the 'price catches cost' timeline again. Combined with the unusual CEO handoff two days later removing a source of continuity reassurance, initial post-print weakness likely extends over the following days rather than reversing, consistent with the Q1 pattern where shares fell further in the days after the print as estimate cuts filtered through. |
MEDIUM |